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ABSTRACT 
Respiratory-gated treatment techniques have been introduced into the radiation oncology practice to manage target 
or  organ  motions.  This  paper  will  review  the  implementation  of  this  type  of  gated  treatment  technique  where  the 
respiratory cycle is determined using an external marker. The external marker device is placed on the abdominal region 
between the xyphoid process and the umbilicus of the patient. An infrared camera tracks the motion of the marker to 
generate a surrogate for the respiratory cycle. The relationship, if any, between the respiratory cycle and the movement 
of the target can be complex. The four-dimensional computed tomography (4DCT) scanner is used to identify this 
motion for those patients that meet three requirements for the successful implementation of respiratory-gated treatment 
technique for radiation therapy. These requirements are (a) the respiratory cycle must be periodic and maintained during 
treatment, (b) the movement of the target must be related to the respiratory cycle, and (c) the gating window can be set 
sufficiently large to minimise the overall treatment time or increase the duty cycle and yet small enough to be within the 
gate.  If  the  respiratory-gated  treatment  technique  is  employed,  the  end-expiration  image  set  is  typically  used  for 
treatment planning purposes because this image set represents the phase of the respiratory cycle where the anatomical 
movement  is  often  the  least  for  the  longest  time.  Contouring  should  account  for  tumour  residual  motion,  setup 
uncertainty,  and  also  allow  for  deviation  from  the  expected  respiratory  cycle  during  treatment.  Respiratory-gated 
intensity-modulated  radiation  therapy  (IMRT)  treatment  plans  must  also  be  validated  prior  to  treatment.  Quality 
assurance should be performed to check for positional changes and the output in association with the motion-gated 
technique. To avoid potential treatment errors, radiation therapist (radiographer) should be regularly in-serviced and 
made aware of the need to invoke the gating feature when prescribed for selected patients. © 2007 Biomedical Imaging 
and Intervention Journal. All rights reserved. 
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INTRODUCTION 
Conformal  radiation  therapy  (CRT)  and  intensity-
modulated  radiation  therapy  (IMRT)  treatment 
techniques require a higher level of accuracy in patient 
setup compared to other traditional treatment techniques. 
This is because CRT requires the leaves of the multileaf 
collimation (MLC) system to conform to the shape of the 
target  area  defined  by  the  beam-eye-view  projection 
while  IMRT  modulates  the  intensity  across  each 
treatment field per gantry angle based on the target shape 
in three dimensions [1-3]. Any unintended deviation in 
patient setup or target motion could lead to having the 
target  outside  and/or  critical  structures  inside  the 
treatment fields resulting in inadequate dose to the target 
and exposure to critical structures. Because of the need 
for higher accuracy, patients are now set up using on-
board  imaging  systems  referred  to  as  image-guided 
radiation  therapy  (IGRT)  [4-5].  Even  with  the 
implementation  of  IGRT  techniques,  residual 
intrafraction motion cannot be completely eliminated and 
hence  has  become  an  important  issue  for  treatments 
performed  with CRT and IMRT, which utilize smaller 
margins.  Respiratory,  skeletal  muscular,  cardiac, 
gastrointestinal systems and other physiologic processes 
can cause intrafraction motion. These motions are very 
natural  and  are  unpredictable  to  an  extent  except  for 
respiratory motion. The impact of respiratory motion on 
targets  and  organs  has  been  reported  by  a  number  of 
investigators. Thoracic tumours  have been observed to 
move  by  more  than  2  cm  [6]. The  movement  of  lung 
lesions has been found to be greatest in the lower lobes 
[7].  Likewise,  the  pancreas  and  kidneys  can  move  by 
more than 2 cm while livers can move by more than 3 
cm. [8-9]. Without the means to limit respiration-induced 
target or organ motion, large treatment fields have to be 
used resulting in the irradiation of surrounding normal 
tissues; and hence increasing the risk of complications. 
Conversely,  if  smaller  treatment  fields  are  used,  the 
target may move out of the treatment field resulting in an 
underdose or margin of miss of the target. 
Some  techniques  such  as  breath-holding,  forced-
shallow  breathing  and  respiratory-gated  treatment 
techniques  have  been  implemented  to  account  for 
respiratory  motion.  In  the  breath-holding  treatment 
technique,  the  patient  is  asked  to  hold  his/her  breath 
during  the  course  of  treatment  [10].  This  treatment 
technique  is  especially  difficult  for  patients  having 
compromised pulmonary function, which is the case for 
most of the lung cancer patients. In the forced-shallow 
breathing treatment technique, a physical plate is placed 
and fixed over the abdominal region to restrict breathing 
motion and thereby limits the excursion of targets and 
organs [11]. The disadvantage of these mechanisms is it 
may cause great patient discomfort. An alternate to the 
normal breathing obstruction methods of treatment is the 
use  of  the  respiratory-gated  treatment  technique.  The 
implementation  of  the  respiratory-gated  treatment 
technique requires some form of marker to generate the 
respiratory cycle on which gating window can be set to 
turn the beam ON within and OFF outside the gate. Two 
types  of  internal  markers  are  being  developed  at 
Hokkaido University [12-13] while an external marker is 
being developed by a commercial vendor. The focus of 
this  paper  is  to  review  the  implementation  of  the 
respiratory-gated  treatment  technique  based  on  an 
external marker as a surrogate signal for target motion. 
METHODS AND MATERIALS 
The  development  of  respiratory-gated  radiation 
therapy  has  been  somewhat  rapid,  hence  a  clear 
understanding  of  the  potential  uses  and  limitations  are 
important.  The  respiratory-gated  treatment  technique 
assumes that the respiratory motion is periodic and the 
target moves in a similar periodic fashion. The radiation 
beam  is  turned  ON  when  the  target  moves  into  the 
treatment  field  as  planned.  Mechanisms  have  been 
introduced  to  synchronise  energising  of  the  radiation 
beam to the respiratory cycle. When using an external 
marker as described below, it should be noted that the 
radiation  is  synchronized  to  turn  ON  based  on  the 
respiratory cycle and not the motion or position of the 
target. Much of the data in this review has been derived 
from articles published in one of the four special issues 
on  image-guided  radiation  therapy  (IGRT)  of  Medical 
Dosimetry  Journal  by  Brandner  et  al  [14],  Jiang  [15], 
Keall et al [16], and Saw et al. [5] in 2006. In addition, 
the  experience  of  implementing  the  respiratory-gated 
treatment technique based on an external marker at this 
author’s institution is incorporated into this manuscript. 
Although  various  vendors  are  introducing 
respiratory-gated devices, the most widely discussed is 
the  Varian  Real-time  Position  Management  (RPM) 
system.  A  passive  marker  block  is  placed  on  the 
abdominal  region  between  the  xyphoid  process  and 
 
Figure 1  The placement of a marker block below the xyphoid 
process  to  generate  respiratory  signal.  [With 
permission from C.B.Saw Publishing]. 
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umbilicus  as  shown  in  Figure  1.  The  position  of 
placement  must  be  carefully  chosen  to  maximize  the 
amplitude  of  the  marker  motion  on  the  patient.  The 
marker  block  is  made  of  plastic  with  two  rounded 
metallic reflectors (separated by 3 cm for calibrating the 
amplitude)  placed  on  one  side.  An  infrared  camera, 
mounted at the foot of the CT table for 4DCT scanning 
and also at the foot of the treatment couch for treatment 
views,  tracks the  movement  of the  markers and hence 
produces  the  respiratory  cycles  as  shown  in  Figure  2. 
The display on the computer monitor running the RPM 
software  includes  an  animated  bar  travelling  up  and 
down following the motion of the marker block on the 
patient  as  a  function  of  time.  A  duplicate  display  is 
placed in the room for the patient to visualise and control 
the amplitude of his/her respiration. The bar travels on a 
blue background, which represents the full range of the 
block  motion  identified  over  the  patient’s  first  few 
respiratory cycles recorded by the RPM system. When 
the patient’s respiratory motion drives the signal beyond 
the range, the bar changes colour indicating to the patient 
that  he/she  should reduce inhaling or exhaling. In this 
manner, the patient can monitor the amplitude of his/her 
respiration and controls the response. In addition, audio 
coaching can also be instituted to improve the periodicity 
of the respiration motion. The audio coach instructs the 
patient  to  “breathe-in”  and/or  “breathe  out”  at  regular 
intervals. The time between each instruction is controlled 
by  the  user  and  can  be  programmed  to  match  the 
patient’s normal respiratory cycle. 
The gating window is set based on the respiratory 
signal  presented  in  Figure  2.  The  maximum  vertical 
movement of the marker block represents the amplitude 
of the signal. The upper portion of the signal represents 
the inhaled phase while the lower portion of the signal is 
the exhaled phase. The distance in time between repeated 
points  on  the  respiratory  cycle  represents  a  complete 
period and is divided into a number of phases of equal 
duration.  Although  the  respiratory  signal  shown  in 
Figure  2  exhibits  excellent  periodicity,  there  are  some 
cases where the amplitude decays or suddenly changes, 
or periodicity changes, reflecting the status of the patient. 
A periodicity filter within the software can be used to 
hold the beam off during such sudden irregularities. The 
gating window is set in two ways referred to as phase 
gating and amplitude gating. In phase gating as shown in 
the figure, the beam “ON” is triggered at a certain point 
past  the  maximum  inhaled  state  and  thereafter  on  the 
onset of inhaling process to inhibit the beam. The gating 
window is typically set when the patient is in the exhaled 
state  where  the  target  moves  the  least.  The  range  in 
amplitude is used to set the gating window in amplitude 
gating. At present, investigation is ongoing as to whether 
phase  gating  or  amplitude  gating  is  optimal  for  the 
treatment. 
As  stated  earlier,  the  movement  of  the  surrogate 
signal may not be directly correlated to the movement of 
the  tumour  or  target.  Hence,  an  assessment  of  the 
correlation  must  be  carried  out  by  performing  4DCT 
scans. There are two types of 4DCT scans identified as 
prospective  and  retrospective  4DCT  scans.  In  the 
prospective  4DCT  scanning  technique,  the  respiratory-
gated CT scanner collects images only at one phase or a 
limited portion of a patient respiratory cycle. Then the 
couch is moved to the next indexed position. The process 
is repeated to obtain one volumetric CT image collected 
at  a  specific  phase  of  the  respiratory  cycle.  In  the 
retrospective 4DCT scanning technique, the respiratory-
gated CT scanner acquires images continuously during 
all phases while the couch remains temporarily stationary. 
Each acquired image is identified by the phase and also 
the couch index position. The couch then moves to the 
next indexed position and the continuous acquisition is 
repeated until the volume of interest has been scanned. 
Each  phase  can  then  be  separately  reconstructed.  The 
outcome  of  retrospective  4DCT  technique  is  the 
acquisition  of  multiple  volumetric  CT  images,  each 
representing one phase of the respiratory cycle. 
 
Figure 2  The marker block signal as a function of time from the RPM system. 
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At  the  University  of  Pittsburgh  Medical  Center 
(UPMC) Cancer Centers and the University of Pittsburgh 
Cancer Institute, the RPM system integrated into the GE 
Lightspeed CT-simulator as shown in Figure 3 is used to 
perform  the  retrospective  4DCT  scans.  Initially,  the 
radiation oncologist identifies patients for whom motion 
is of concern. However, the patient must be assessed to 
have  a  periodic  respiratory  cycle  and  uncompromised 
pulmonary  function,  and  is  stable.  Once  the  patient 
arrives  at  the  medical  centre,  the  procedure  of 
performing the 4DCT scan is described to the patient. 
Patient positioning is instituted by designing the patient 
support system, by arranging the immobilisation devices, 
and by using treatment aids. After the patient positioning 
procedure is complete, a marker block is placed on the 
patient  abdominal  region  and  the  RPM  system  is 
activated.  The  CT  technologist  or  radiation  oncology 
physicist explains and instructs the patient to perform the 
breathing  sequence  in  response  to  the  audio  coaching 
instructions of “breathe in” followed by an exhale in a 
manner that the patient feels comfortable with, between 
each instruction.  
An initial scout view and a helical CT scan through 
the volume of interest are acquired, and at the same time, 
the  marker  motion  is  monitored  to  identify  the 
respiratory cycle and also the inhalation and exhalation 
times.  Next,  the  tracing  of  the  respiratory  cycle  is 
evaluated with audio coaching implemented to set up the 
system.  The  longest  observed  time  is  entered  into  the 
audio coaching configuration since most patients breathe 
more deeply in response to coaching. The mono-phasic 
audio  coaching  (i.e.  “breathe  in”)  is  activated  and  the 
patient is instructed to follow the coaching instructions. 
The rhythm of the coaching instruction is adjusted until 
the patient is comfortable with the pace. Once the audio 
coaching  pace  is  established,  the  CT-simulator  is 
programmed to acquire in the cine acquisition mode that 
is  to  remain  at  each  couch  location  for  the  entire 
respiratory  cycle  plus  one  second  and  to  acquire  an 
image  in  a  fraction  (typically  one-tenth)  of  the 
respiratory  cycle.  This  allows  the  CT-simulator  to 
acquire multiple images throughout the respiratory cycle 
at the same couch location. A slice thickness of 2.5 mm 
is  commonly  used  for  4DCT  scans  at  this  author’s 
institution. For example, if images are acquired every 0.5 
seconds for a 5-second breathing cycle, it results in 10 
images representing 10 different phases of the respiratory 
cycle.  With  the  programmed  time  of  one  additional 
second, 12 images are acquired instead of 10 images, two 
of which are extra images. The rationale for extending an 
additional second is to accommodate slight changes in 
the patient’s respiratory cycle. When all the images at 
one  couch  location  have  been  acquired,  the  radiation 
beam is turned off and the couch automatically moves to 
the  next  indexed  position  and  the  scanning  continues. 
Since  the  CT-simulator  and  RPM  system  are  separate 
devices, they must be synchronised in the temporal space. 
A “scanner on” signal is sent to the RPM computer only 
when the CT-simulator is performing the scanning. Once 
the entire scan is complete, this signal and the breathing 
cycle are stored in a file and along with the CT images 
are exported to the GE AdvantageSIM workstation. At 
the  AdvantageSIM  workstation,  the  images  are  sorted 
according to their phases in a series of three-dimensional 
(3D) images, each representing a different phase of the 
respiratory cycle. 
After the phases are chosen for gating, the image set 
of  the  end-expiration  phase  and  all  phases  within  the 
gating window are forwarded to the treatment planning 
system for the generation of a treatment plan. The end-
expiration phase image set is chosen for contouring and 
planning  because  it  represents  the  phase  where  the 
anatomical  structures  typically  move  the  least  for  the 
longest time. On the respiratory cycle, it is depicted as a 
relatively  “flat”  signal  at  the  minimum  position  (end-
expiration  phase)  on  Figure  2.  However,  neighbouring 
phases  within  the  gating  window  can  correspond  to  a 
time where the target and organs begin to move rapidly. 
Planning  tools  are  often  used  to  fuse  images  from 
different phases to determine the overall internal target 
volume (ITV). Contouring is done on the end-expiration 
phase  image  set  but  must  include  the  location  of  the 
target and structure in all phases within the gate plus an 
additional margin for residual motion uncertainties. For 
lung  targets  where  the  background  exhibits  low 
Hounsfield (HU) numbers, all phases can be combined 
into  a  composite  image.  The  maximum  intensity 
projection (MIP) image constitutes a visualisation of the 
maximum extent of the target movement. Because of the 
large contrast between lung and target in the composite 
image,  edge  detection  can  be  used  to  define  the  ITV, 
making  contouring  and  planning  simpler  instead  of 
image sets of all phases within the gate. 
For  respiratory-gated  radiation  therapy,  the  RPM 
system must be available at the treatment machine. The 
patient  setup  would  be  the  same  and  the  patient  is 
coached in the same manner as during 4DCT scans. The 
respiratory-gated  treatment  technique  is  mechanically 
 
Figure 3  The location of the infrared camera at the foot of the 
couch  for  tracking  the  marker  block  in  the  RPM 
system. 
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invoked  prior  to  initiating  treatment.  The  radiation 
therapists (radiographers) should monitor the respiratory 
cycle  very  carefully  during  dose  delivery  since  the 
periodicity of the motion can change if the patient fails to 
follow  the  coaching  instructions  possibly  resulting  in 
inaccurate treatment. Predictive filters can be enabled in 
the software to limit this possibility. 
Individualised  respiratory-gated  IMRT  treatment 
plans must also be validated prior to patient treatment. 
The validation procedure involves irradiating a phantom 
using  individualised  patient  treatment  parameters.  The 
phantom setup used at this author’s institution is shown 
in  Figure  4  with  an  ion  chamber  positioned  at  the 
isocenter and an EDR2 film positioned in a plane 1 cm 
above the isocenter. The monitor units, field geometries, 
fluence maps, and leaf sequences used for irradiation is 
the same as those used to treat the patient. The planning 
system is used to generate a hybrid test plan matching 
this validation delivered to the phantom for comparison 
purposes.  After  the  dose  delivery,  the  measured  dose 
using the ion chamber is compared to the planned dose. 
In  addition,  the  film  is  developed  and  the  isodose 
distribution  is  measured  using  film  dosimetry  and 
compared  to  the  isodose  distribution  in  that  plane  as 
planned.  
RESULTS 
After completing the retrospective 4DCT scans, the 
motion  of  the  target  in  each  respiratory  phase  can  be 
traced  and  evaluated  throughout  the  respiratory  cycle. 
Since the CT images are acquired sequentially, the time 
resolution of the images represents the time difference 
between the phases. The superposition of images from 
different phases provides an idea of the relative motion 
of the target as shown in Figure 5. If respiratory-gated 
radiation therapy is selected, the number of phases used 
forms  the  gating  window  size  with  a  defined  residual 
tumour motion. The residual tumour motion (maximum 
motion of the target within the treatment field) has been 
analysed in phantom studies and a motion of up to 5 mm 
was  found  to  be  acceptable  for  the  respiratory-gated 
IMRT treatment technique [18]. With this criterion, the 
end-expiration  phase  and  its  neighbouring  phases  are 
selected such that the target motion is kept to less than 5 
mm. As many phases as possible should be included in 
the  gating  window  to  reduce  the  treatment  time  (i.e. 
maximising the duty cycle). If all the phases are included, 
it indicates gating is not needed. Based on this author’s 
experience,  an  approximate  phase  range  of  30%-70% 
with a residual target motion of 5 mm within the gate is 
common. 
Brandner et al. [14] at the University of Pittsburgh 
Cancer  Institute  has  investigated  the  motion  of  some 
organs using the 4DCT scanning technique. They found 
that the organ motion is typically in the inferior-superior 
direction with an average of 12-15 mm for the kidneys, 
15  mm  for  the  liver  and  spleen,  and  10  mm  for  the 
   
Figure 4  Phantom  setup  to  perform  patient  specific  dose 
validation. [With permission from C.B. Saw Publishing]. 
Figure 5  The relative motion of the target at three different phases. 
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pancreas. Very little motion was seen in the left and right 
direction typically less than 3 mm for abdominal organs. 
In addition, the actual movement of the organs may span 
two or three dimensions indicating that organs must be 
evaluated in three dimensions on all respiratory phases. 
They  also  note  that  the  superior  lobe  tumours  move 
much less than inferior lobe tumours. 
The  intent  of  respiratory-gated  IMRT  plan 
validation  is  to  verify  that  the  correct  dose  and  dose 
distribution will be delivered to the patient. Generally, a 
point dose  measurement is taken  with an ion chamber 
and the difference between the measured dose and the 
calculated  dose  should  be  within  5%.  In  addition,  the 
dose distribution in a plane is measured and compared to 
the treatment plan as shown in Figure 6. At this author’s 
institution,  the  difference  in  isodose  levels  of 
individualised treatment plan should be within 3 mm or 
3% in high-dose region and with 5 mm and 5% in low-
dose region to be considered acceptable. 
Figure  7  illustrates  the  effectiveness  of 
implementing the respiratory-gated treatment technique. 
The  upper  left  image  of  the  figure  is  the  digitally 
reconstructed  radiograph  (DRR)  and  the  upper  right 
image is the portal image acquired during the treatment. 
The  lower  left  represents  an  image  when  the  patient’s 
respiration was outside the respiratory gate and therefore 
the image is blurred since it was acquired while the beam 
was held. The lower right image was acquired when the 
beam came back on within the gate. Since the structures 
within the ports are observed not to move relative to the 
DRR  images,  it  demonstrates  the  accuracy  of  the 
respiratory-gated  treatment  technique  for  radiation 
therapy. 
DISCUSSION 
For the purpose of discussion, it should be pointed 
out that there is no basis for establishing the correlation 
between respiratory motion based on an external marker 
and the movement of the target. First, the dimension of 
the system is different. The respiratory motion is inferred 
based on the detection and recording of the marker block 
movement  in  the  anterior-posterior  dimension.  On  the 
other hand, the target or tumour, if mobile, can move in 
three dimensions in a complicated fashion. Second, it is 
well known that fixed tumours such as those fixed to the 
rib cage may not move in any synchronised fashion with 
the respiratory motion. Third, the work of Brandner et al. 
[14] has demonstrated that tumours in the lung move at 
different  rates  depending  on  their  locations  within  the 
lung. However, the respiratory-gated treatment technique 
can  be  employed  for  a  subset  of  patients  determined 
using 4DCT scans where the target movement relative to 
the  respiratory  cycle  is  observed  and  assumed  to  be 
correlated to the respiratory cycle. 
The 4DCT scanning technique allows a mechanism 
of establishing the relationship between the phases of the 
respiratory  cycle,  the  gating  window,  and  the  tumour 
residual  motion.  If  the  gate  is  opened  completely, 
implying  that  there  is  no  gating,  the  tumour  residual 
motion  can  be  very  large.  This  type  of  radiation 
treatment  would  require  large  margins  resulting  in  the 
use of large treatment fields. If the gate can be restricted, 
the  tumour  residual  motion  would  be  smaller.  This 
means that the radiation beam is turned ON within the 
gate as the target resides within the treatment field. If the 
tumour  residual  motion  is  further  limited  for  an  even 
smaller margin, the gate has to be made very small and 
thereby decreasing the duty cycle. The duty cycle is the 
ratio of the beam-on treatment time to the total treatment 
time.  The  objective  of  the  respiratory-gated  treatment 
technique is to search a means of increasing the gating 
window as large as possible for a defined (or smaller) 
tumour residual motion specification. 
By  its  very  nature,  the  respiratory-gated  treatment 
technique accounts for the positional change with time 
and hence positional quality assurance is important. The 
performance  of  a  positional  check  involves  taking 
respiratory-gated CT images of a motion phantom from 
which  to  create  the  digital  reconstructed  radiographs 
(DRRs).  The  same  phantom  is  then  set  up  in  the 
treatment  room  from  which  respiratory-gated  portal 
images are acquired. The comparison of the respiratory-
gated DRRs and respiratory-gated portal images provide 
estimates of the geometric uncertainty of the treatment 
delivery  system  under  ideal  conditions.  It  should  be 
noted  that  this  quality  assurance  does  not  address  the 
issue of patient setup and variability of patient breathing 
motion during the course of treatment. The dosimetric 
errors associated with patient setup and breathing motion 
variability have been discussed in the report published by 
AAPM  Task  Group  76  [19].  In  addition  to  positional 
confirmation,  the  dosimetry  quality  assurance  involves 
measuring dose delivered to a moving phantom using a 
gated plan and comparing this to the dose delivered to 
the  phantom  while  stationary.  This  provides  assurance 
that  the  machine  output  is  basically  same  with  and 
without gating. The introduction of the respiratory-gated 
treatment  technique  has  produced  the  risk  of 
mistreatment where the radiation therapist (radiographer) 
may  fail  to  invoke  the  respiratory-gated  technique, 
invoking  the  respiratory-gated  technique  when  not 
prescribed,  or  treating  another  patient  with  a  different 
patient’s respiratory-gated parameters. Hence, radiation 
therapists  (radiographers)  must  be  more  vigilant  in 
reviewing  the  additional  gating  instructions  and 
observing the respiratory trace. 
SUMMARY 
To  summarise,  the  respiratory-gated  treatment 
technique using an external marker can be successfully 
implemented on selected patients. A requirement for the 
successful  use  of  the  respiratory-gated  treatment 
technique  is  the  need  for  the  respiratory  cycle  to  be 
periodic, reproducible, and maintained during treatment. 
This may not be possible for all patients especially those 
patients  with  compromised  pulmonary  function. 
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Figure 7  Comparison between DRR and portal images of a gated treatment 
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Coaching  should  be  used  to  assist  in  producing  and 
maintaining  the  periodicity  of  the  respiratory  signals. 
The  respiratory-gated  treatment  technique  is  ideal  for 
lung  and  gastrointestinal  cancer  patients  since  its 
utilisation  may  potentially  reduce  radiation  damage  to 
surrounding normal tissues. However, the prerequisites 
require  cautious  assessment  of  respiratory  motion  in 
these patients. The movement of the target or adjacent 
organ(s) must be correlated to the respiratory cycle. The 
gating  window  should  be  reasonably  large  based  on  a 
specified tumour residual motion to maximise the duty 
cycle.  4DCT  scanning  is  performed  to  evaluate  and 
identify  those  patients  that  may  benefit  from  this 
advanced  radiation  treatment  technique.  If  the 
respiratory-gated  treatment  technique  is  employed,  the 
treatment  planning  is  performed  on  the  end-expiration 
image set or a MIP image set that include all treatment 
phases. Contouring includes the tumour residual motion 
and an additional  margin to  allow  for  minor deviation 
from the respiratory cycle. Lastly, the respiratory-gated 
IMRT  plans  must  also  be  validated  prior  to  patient 
treatment  to  ensure  that  the  doses  are  delivered  in 
accordance to the treatment plan. Since respiratory-gated 
treatment technique is only used for selected patients and 
it  is  an  add-on  device,  radiation  therapists  (or 
radiographers) are advised to be aware of invoking the 
gating  technique  when  prescribed  and  be  vigilant  in 
observing  additional  parameters  during  treatment. 
Quality  assurance  aspects  on  the  respiratory-gated 
treatment  technique  must  address  the  positional  and 
output change with time requiring a specialised motion-
dependent phantom. 
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